The Latest Breaking News from Pfizer

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.

Some people in Hong Kong have been acting suspiciously to get their hands on Covid-19 antiviral drugs, the Post has learned, with one person going to six doctors in a single day asking for the same medicine.

New data from one U.S. Centers for Disease Control and Prevention (CDC) database shows a possible stroke risk link for older adults who received an updated Pfizer/BioNTech COVID-19 booster shot, but the signal is weaker than what the agency had flagged earlier in January, health officials said on Thursday.

The Packers quarterback gets asked about trade rumors, calls out woke culture, Big Pharma.

Stéphane Bancel, the chief executive of drug company Moderna, could barely restrain his pride in issuing his annual letter to shareholders on Jan. 3.

The President’s Emergency Program for AIDS Relief, or PEPFAR, has revolutionized the fight against global AIDS over the last 20 years. In that time, the U.S. program has brought antiretroviral treatment to nearly 19 million people living with HIV, the virus that causes AIDS; prevented mother-to-child transmission of HIV for…

Americans will get a clearer idea of how often they’ll roll up their sleeves for COVID-19 shots when advisers to U.S. regulators meet Thursday to discuss an immunization schedule that looks more like the one used for flu.

People in the US have been sharing videos on social media showing them seemingly trembling and shaking

A Pfizer booster that specifically tackles two Omicron COVID-19 variants has been given provisional approval by the Therapeutic Goods Administration.